drugset / Trial / NCT02345733

Use of a Novel Diet (UC DIET) for Treatment of Mild to Moderate Active Pediatric Ulcerative Colitis

NCT02345733

Phase 4 Completed 20 enrolled Prof. Arie Levine
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The goal of the study is to evaluate strategies that target the microbiota for the treatment of Ulcerative Colitis , This study will involve a novel diet that the investigators developed , based on the hypothesis that UC involves dysbiosis , underutilzation of certain metabolic pathways and use of pathways that increase risk of inflammation . The investigators have postulated that manipulation of colonic bacterial metabolism with this diet will induce remission in UC without involving additional immune suppression.

Timeline

Start
2015-09-01
Primary completion
2021-10-29
Completion
2021-10-29

Drugs

EvaluationDrugModalityDoseRoute
Subject Amoxicillin Other / unclassified
Subject Doxycycline Small molecule
Subject Metronidazole Small molecule

Indications